Last reviewed · How we verify

NCT03066596: PRAGMATIC

Promoting Asthma Guidelines and Management Through Technology-Based Intervention and Care Coordination

Completed NA Results posted Last updated 21 October 2025
What this trial tests

NA trial testing eMPI in Asthma Childhood in 530 participants. Completed in 24 August 2024.

Timeline
7 March 2017
Primary endpoint
24 August 2024
24 August 2024

Quick facts

Lead sponsorMontefiore Medical Center
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment530
Start date7 March 2017
Primary completion24 August 2024
Estimated completion24 August 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Montefiore Medical Center

Who can join

Adults 2 to 12, any sex, with Asthma Childhood. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Percentage of Participants With 1 or More Guideline-based Corrective Actions Taken Primary · Immediately post-intervention, up to 1 year

The percentage of participants with 1 or more guideline-based corrective actions taken (i.e., controller medication prescription or adjustment, trigger evaluation), as recorded in the electronic health record (EHR) is reported. Results are summarized in number/percentage of participants with 1 or more guideline-based corrective actions taken by study arm.

GroupValue95% CI
Enhanced Multifaceted Prompting Intervention (eMPI)241
Enhanced Usual Care (eUC) Practices197
Symptom Free Days (SFDs) Secondary · Baseline, and 3 month, 6 month, 9 month, and 12 month follow-up evaluations

The number of days without symptoms during the past 14 days is summarized by study arm at baseline and every 3 months up through the 12 month follow up evaluation.

Baseline
GroupValue95% CI
Enhanced Multifaceted Prompting Intervention (eMPI)5.79± 4.70
Enhanced Usual Care (eUC) Practices6.41± 4.72
3 month
GroupValue95% CI
Enhanced Multifaceted Prompting Intervention (eMPI)9.33± 4.95
Enhanced Usual Care (eUC) Practices9.17± 4.82
6 month
GroupValue95% CI
Enhanced Multifaceted Prompting Intervention (eMPI)9.68± 4.52
Enhanced Usual Care (eUC) Practices10.33± 4.06
9 month
GroupValue95% CI
Enhanced Multifaceted Prompting Intervention (eMPI)10.07± 4.37
Enhanced Usual Care (eUC) Practices10.78± 4.36
12 month
GroupValue95% CI
Enhanced Multifaceted Prompting Intervention (eMPI)10.53± 4.16
Enhanced Usual Care (eUC) Practices10.44± 4.49

Sponsor's own description

The overall goal of this research study is to test the effectiveness of a multifaceted and multi-level prompting intervention in a real world urban primary care office setting on improving provider-delivered guideline-based asthma care and reducing asthma morbidity among urban children with persistent or uncontrolled asthma.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Unmet Social Needs and Pediatric Asthma Severity in an Urban Primary Care Setting.
    Telzak A, Fiori KP, Chambers EC, Haughton J, et al · · 2023 · cited 13× · PMID 36858248 · DOI 10.1016/j.acap.2023.02.009
  2. Patient navigator programmes for children and adolescents with chronic diseases.
    Lalji R, Koh L, Francis A, Khalid R, et al · · 2024 · cited 7× · PMID 39382077 · DOI 10.1002/14651858.cd014688.pub2
  3. The COVID-19 pandemic and asthma management: a family caregiver perspective.
    Reznik M, Ball-Jones R, Ibarra J. · · 2025 · PMID 39726143 · DOI 10.1080/02770903.2024.2447285

Verify or expand the search:

Other recruiting trials for Asthma Childhood

Currently open trials in the same condition.

Other Montefiore Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03066596.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing